Home › Bladder Cancer › NCT03413982

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
* Patients can participate in any additional research studies during the patients' participation within this protocol.

Exclusion Criteria:

* Patients who do not have presumed bladder cancer will not be eligible

About the study

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

What is being tested

• Registry (other)

Sponsor: University of Kansas Medical Center · Participants: 1,000 · Started: Nov 2, 2017

Contact the study team

• Jane Ladesma · Phone: 913-588-8721

Official record on ClinicalTrials.gov — NCT03413982

Locations in the U.S.

Conditions

• Bladder Cancer

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.